Orenitram FDA Approval History
FDA Approved: Yes (First approved December 20, 2013)
Brand name: Orenitram
Generic name: treprostinil
Dosage form: Extended-Release Tablets
Company: United Therapeutics Corporation
Treatment for: Pulmonary Arterial Hypertension
Orenitram (treprostinil extended-release) is an oral prostacyclin for the treatment of pulmonary arterial hypertension.
Development timeline for Orenitram
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
